Answers are grounded in this paper and cite their sources.
MRD positivity, but in these high-risk patients, the significant incidence of leukemia relapse must be tackled by post-transplant preemptive treatments.
No takes yet. Share an insight, caveat, or question.
Lussana et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: